These plans also usually include a deductible and a monthly premium
Tirzepatide 15 mg (the highest available dose) was the most effective in lowering A1c versus placebo (mean difference [MD], 2%, 95% CI -2.16 to -1.84), followed by tirzepatide 10 mg (MD -1.86%, 95% CI -2.02 to -1.84) and semaglutide 2 mg (MD, 95% CI -1.62%, -1.96 to -1.28)
Eli Lilly Press Release: Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial
The FDA does not check whether whats listed on the label is actually present in the pill, powder, or gummy in safe, accurate, or effective amounts
(verified owner) Rated 5 out of 5 Works perfectly
Agree that since you already maintain caloric deficit you likely get very marginal benefits